The expression of secretory group IIA phospholipase A2 (sPLA2-IIA) has been shown to be elevated in various inflammatory diseases, and lipopolysaccharide (LPS) up-regulates the expression of sPLA2-IIA in human umbilical vein endothelial cells (HUVECs). Pelargonidin (PEL) is a well-known red pigment found in plants, and has been reported as having important biological activities that are potentially beneficial for human health. Here, PEL was examined for its effects on the expression and activity of sPLA2-IIA in HUVECs and mouse. Post treatment of cells or mouse with PEL inhibited LPS-induced expression and activity of sPLA2-IIA. Therefore, these results suggest that PEL inhibited LPS mediated expression of sPLA2-IIA.
The systemic vascular inflammatory response in endotoxemia can lead to rapid organ failure, shock, and death [1] [2] . It represents a major burden to the health care system, with more than 400,000 cases/year in the United States alone [1] . Presence of lipopolysaccharide (LPS), a bacterial endotoxin, ranks the highest among the risk factors contributing to lethal endotoxemia [3] . Endotoxins are known to activate innate immune responses, resulting in the production of a vast spectrum of inflammatory cytokines [1, 4] . These pro-inflammatory cytokines are known to trigger vascular endothelial activation [2] . Secretory PLA2 (sPLA2) is a small 14 kDa enzyme and found in the venom of certain snakes (types IA, IIA, and IIB), pancreatic juices (type IB), rat and mouse testes (type IIC), placenta, synovial fluids and plateles (type IIA), and heart, lung, and P388D1 macrophage (type V) [5] . Secretory phospholipase A2 group IIA (sPLA2-IIA) is a member of the secreted phospholipase family of lipid hydrolyzing enzymes that hydrolyses the ester bond at the sn-2 position of phosphoglycerides to release free fatty acid and lysophospholipids [5] [6] . And these isoenzymes have been reported in various activities such as production of lipid mediators contributing to inflammation, tumorigenesis, bacterial defense, fertilization, and phospholipids digestion in the gastrointestinal track [5] . A high expression level for this enzyme has been observed at inflamed sites and also in the serum of patients with inflammatory disorders such as sepsis, septic shock, polytrauma and atherosclerosis [7] [8] [9] [10] . During acute or chronic inflammation, the level of sPLA2-IIA expression has been shown to correlate with the severity of the disease [7, 11] . Moreover, it has been demonstrated that sPLA2-IIA promotes inflammation in animal models [12] [13] .
Pelargonidin (PEL) has been found in blue, purple, and red fruits and vegetables such as plums and red beans, and has been reported to be having antioxidant and antidiabetic activities in vivo [14] [15] [16] [17] [18] . Recently, pelargonidin has been reported to be having antiinflammatory and anti-carcinogenic activities, and have been shown to be effective in cardiovascular disease prevention and diabetes management [19] [20] . Although some biological activities and pharmacological functions of PEL have been reported, the effects of PEL on the expression and activity levels of sPLA2-IIA have not been previously determined. Since the induction of sPLA2-IIA in endothelial cells is related with inflammation, in this study, it is hypothesized that PEL might reduce the expression and activity levels of sPLA2-IIA.
The concentration-dependence of the LPS-mediated expression of sPLA2-IIA in primary human endothelial cells is determined. Analysis of the expression level of sPLA2-IIA by the transformed HUVECs in response to varying concentrations of LPS for 24 h indicated that the induction level reaches plateau in cell culture supernatants at 100 ng/mL LPS. A similar effect for LPS was observed if endothelial cells were cultured in serum free medium containing 0.2% bovine serum albumin (BSA), excluding the possibility that the effect of LPS on sPLA2-IIA expression is due to its interference with the function of some unknown factors in the serum. Based on these results, a LPS concentration of 100 ng/mL was used to stimulate endothelial cells in all experiments described below. First, we tested the effects of PEL on the expression and activity of sPLA2-IIA induced by LPS in HUVECs. Data showed that post-treatment of PEL (at 10 -30 M) potently inhibited the expression (Fig. 1A) and activity sPLA2-IIA (Fig. 1B) . We next determined the IC 50 of PEL on the effect on LPS induced sPLA2-IIA activity. It showed that IC 50 of PEL was 27.3 M. Thus, these results suggest that the expression and activity sPLA2-IIA was significantly inhibited by PEL, indicating that PEL had a significant effect on this enzyme.
PEL was evaluated for their inhibition of sPLA2-IIA expression using a model of LPS-injected endotoxemia or cecal ligation and puncture (CLP)-induced sepsis mouse to confirm above indicated in vitro efficacy. Presence of LPS, a bacterial endotoxin, ranks the highest among the risk factors contributing to lethal endotoxemia [3] . Endotoxins are known to activate innate immune responses, resulting in the production of a vast spectrum of inflammatory cytokines [1, 4] . These pro-inflammatory cytokines are known to trigger vascular endothelial activation [2] . And, the CLP model of sepsis was used to determine the concentrations of serum sPLA2-IIA present in severe vascular inflammatory diseases because the CLP model closely resembles human sepsis [21] . At 24 h after the operation, animals manifested signs of sepsis, such as shivering, bristled hair, and weakness. The results (Fig. 2) , post-treatment with PEL showed a marked reduction in the sPLA2-IIA expression in both LPS-injected or CLP-induced sepsis mouse.
LPS-induced phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and cPLA2α in HUVECs were attenuated by 20 or 30 μM of PEL (Fig. 3A) . Thus, the roles of ERK 1/2 and cPLA2α were tested by activation in 100 ng/mL LPS-mediated sPLA2-IIA expression in HUVECs. When HUVECs were pretreated with 5 μM U0126 or 20 μM AACO before LPS stimulation, sPLA2-IIA expression were significantly reduced compared to the cells treated with LPS only (Fig. 3B ). These data indicated that 100 ng/mL LPS-induced the activation of ERK 1/2 and cPLA2α can regulate the expression of sPLA-IIA, and the inhibitory effects of PEL on LPS-mediated sPLA-IIA production were originated from the suppressed phosphorylation of ERK 1/2 and cPLA2α. Furthermore, PEL showed a marked reduction in the activation of p38 mitogen-activated protein kinase (MAPK) and JNK in LPSactivated HUVECs (Fig. 3C) .
The sPLA2-IIA seems to play a role in the initiation and propagation of vascular inflammation such as severe sepsis, septic shock and polytrauma [8] [9] [22] [23] [24] [25] [26] . Supporting this, a high level of this molecule has been found in the sera of patients with inflammatory disorders [8, [23] [24] [25] [26] . However, the possibility that sPLA2-IIA is only an inflammatory marker rather than a contributor to inflammation, has not been ruled out because selective sPLA2-IIA inhibitors were treated to septic patients or rheumatoid arthritis to oppose the abnormal production of sPLA2-IIA but failed to improve the clinical outcome [27] [28] . Thus, another clinically improved tool is needed to treat severe vascular inflammatory diseases. In this context, PEL might be the alternative candidates for the treatment of severe vascular inflammatory diseases based on the inhibitory effects of PEL on the expression and activity of sPLA2-IIA, which is supported the previous reports which showed that the hyper-permeability was found in sPLA2-IIA transgenic mice [29] and the inflammatory chemokines and cell adhesion molecules were induced by sPLA2-IIA itself directly [30] .
In conclusion, the inhibitory effect of PEL on the expression and activity of sPLA2-IIA may contribute the anti-inflammatory effects of PEL in endothelium via the inhibition of cPLA2 and ERK 1/2.
Experimental
Cell culture: Primary HUVECs were obtained from Cambrex Bio Science Inc. (Charles City, IA) and maintained as described as before [31] [32] .
Animals and husbandry:
Male C57BL/6 mice (6-7 weeks old, weighing 27 g), purchased from Orient Bio Co. (Sungnam, Republic of Korea), were used after a 12-day acclimatization period. Animals were housed five per polycarbonate cage under controlled temperature (20-25°C) and humidity (40-45%) and a 12:12 h light: dark cycle. Animals received a normal rodent pellet diet and water ad libitum during acclimatization. All animals were treated in accordance with the 'Guidelines for the Care and Use of Laboratory Animals' issued by Kyungpook National University (IRB No. KNU 2016-54).
CLP; To induce sepsis, male mice were anesthetized with Zoletil (tiletamine and zolazepam, 1:1 mixture, 30 mg/kg) and Rompum (xylazine, 10 mg/kg). The CLP-induced sepsis model was prepared as previously described [32] [33] . In brief, a 2 cm midline incision was made to expose the cecum and adjoining intestine. The cecum was then tightly ligated with a 3.0 silk suture 5.0 mm from the cecal tip and punctured once using a 22-gauge needle to induce sepsis. The cecum was then gently squeezed to extrude a small amount of feces from the perforation site and returned to the peritoneal cavity. The laparotomy site was then sutured with 4.0 silk. In sham control animals, the cecum was exposed, but not ligated or punctured, and then returned to the abdominal cavity. This protocol was approved by the Animal Care Committee at Kyungpook National University prior to conducting the study (IRB No. KNU 2016-54).
Effect of pelargonidin on sPLA2-IIA Natural Product Communications Vol. 13 (8) 2018 965 ELISA for sPLA2-IIA expression: The level of sPLA2-IIA protein in the cell culture medium was determined by using specific ELISA kit (Cayman Chemical, Ann Arbor, MI) as described previously [34] [35] according to the manufacturer's instruction. Primary HUVECs were activated with control serum free media or 100 ng/mL LPS for 24 h, followed by incubating with indicated concentrations of PEL for 6 h. Or, cells were incubated with U0126 (5 M) or AACO (20 M) for 2 h. Or, LPS injection (15 mg/kg, i.p.) or CLP-operated mice were post-treated with PEL (0.26 or 0.39 mg/kg) for 6 h. After 2 days, plasma was prepared. Then, diluted medium or mouse plasma was added to each well of the plate. Then, an acetylcholinesterase-sPLA2-Fab' conjugate was added to each well after washing. The concentration of the analyte was measured by adding Ellman's reagent to each well and reading the product of the acetylcholinesterase catalyzed reaction in an ELISA plate reader (Tecan, Mannedorf, Switzerland) at 412 nm. sPLA2-IIA concentrations in the samples were calculated from a standard curve using recombinant sPLA2-IIA as an a standard.
Assay for the sPLA2-IIA activity: The activity of sPLA2-IIA was measured, using 1-palmitoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-3-phospho-ethanolamine (NBD-PE, AvantiPolar-lipid, Inc., Alabama) as a substrate, as reported previously [36] . Reaction mixtures (total 100 L) comprising 50 mM Tris-HCl (pH 8.0), 123 M NBD-PE, 2 mM Ca 2+ and the indicated mounts of sPLA2-IIA were incubated for 30 min at 30°C in the presence or absence of the indicated concentrations of PEL .
Western blot analysis:
Protein concentration was measured by using a bovine serum albumin (BSA) protein assay kit and loaded on the 10% Acrylamide-SDS-PAGE at 120 V in duplicates for electrophoresis and then transferred to nitrocellulose membranes at 200 mA for one hour. Membranes were then blocked in Trisbuffered saline, pH 7.4 (TBS) with 0.1% Tween 20 (TBS-T) containing 5% non-fat milk for 1 hour at room temperature and then incubated with primary antibodies against phospho-ERK1/2 and ERK1/2 (1:10000), phospho-cPLA2a and cPLA2a (1:1000) overnight at 4°C. After washing with TBS-T, blots were incubated with secondary antibodies for one hour at room temperature. Immunolabeling was detected by ECL (Millipore). Densitometry analysis was performed using the ImageJ Gel Analysis tool.
ELISA for p38 MAPK and JNK:
The activity of phosphorylated p38 MAPK (Cell Signaling Technology, Danvers, MA) and JNK (R&D Systems, Minneapolis, MN)was quantified in accordance with the manufacturer's instructions using a commercially available ELISA kit.
Statistical Analysis:
All experiments were performed independently at least three times. Values are expressed as means ± standard deviation (SD). The statistical significance of differences between test groups was evaluated using SPSS for Windows, version 16.0 (SPSS, Chicago, IL). Statistical relevance was determined by oneway analysis of variance (ANOVA) and Tukey's post-hoc test. P values less than 0.05 were considered to indicate significance.
